Scheduled maintenance will begin on May 30th, 2025. Server will be temporarily unavailable — learn more.
current user: public
If you have questions about the server, please let us know.

Query: [O] COG5207 Isopeptidase T, from VFDB

Results of FFAS03 search in VFDB
Master-slave alignment(slide right to see more) does not show gaps in the query sequence, use ali links to display alignment between query and templates.
    .   10    .   20    .   30    .   40    .   50    .   60    .   70    .   80    .   90    .  100    .  110    .  120    .  130    .  140    .  150    .  160    .  170    .  180    .  190    .  200    .  210    .  220    .  230    .  240    .  250    .  260    .  270    .  280    .  290    .  300    .  310    .  320    .  330    .  340    .  350    .  360    .  370    .  380    .  390    .  400    .  410    .  420    .  430    .  440    .  450    .  460    .  470    .  480    .  490    .  500    .  510    .  520    .  530    .  540    .  550    .  560    .  570    .  580    .  590    .  600    .  610    .  620    .  630    .  640    .  650    .  660    .  670    .  680    .  690    .  700    .  710    .  720    .  730    .  740    .  750    .  760    .  770    .  780    .  790    .  800
# Score Template Links and tools%idFirst MAVEMTGKFIQKESPKSFSHSEMAEAVLENVNVPAVVSKDECIYCFESPYNEPLALNASPKHSLNICLNCFQATCNRHVPLHIRVTEYACDTIHSNYLTIAKVEKPKQENVEENNNNKKIKLQVIETSEDDTHNTIWSLQRFNGENVPRTVLSKSTDSDISSTALEKIEKILKAKSQDFEDKKNSWVLEISTCPHTENFQIPSKPENTVNLNQCSSCDLTQNLWLCLHCGNIGCGREQIGIDGHSHALDHYRSNNNHPLAIKLGSLSSSTYDLYCYACDDETRFPDNVNLGSALQIYGINIQEKIADEKTLVQLQVEQNENWQFRMVDSSGKEFEKLSASKNYGCGLINLGNSCYLNSVIQSLVNGGVPNWSLDFLGSKFPLDVVYPDNNLKCQWIKLLNAMKCEPELYPNGIKPTTFKKCIGQNHQEFSSNRQQDAMEFLTFLLDLLDKKFFSSSSSGIPNPNDLVRFMMEDRLQCNICGKVKYSYEPTEAIQIPLEENDEPQDMLERIKAYFEGQTIEFKCANCKEKVTANKKPGFKSLPQTLILNPIRIRLQNWIPVKTSNELSLPGLIDRDDMLDVSSYLSQGFDPQTENLLPDEDENRSSFTPNQCSISQLIEMGFTQNASVRALFNTGNQDAESAMNWLFQHMDDPDLNDPFVPPPNVPKKDKREVDEVSLTSMLSMGLNPNLCRKALILNNGDVNRSVEWVFNNMDDDGTFPEPEVPNEEQQQKKDLGYSTAKPYALTAVICHKGNSVHSGHYVVFIRKLVADKWKWVLYNDEKLVAADSIEDMKKNGYIYFYTRCLast
1 -232.000[O] COG5207 Isopeptidase T  ali  100  1MAVEMTGKFIQKESPKSFSHSEMAEAVLENVNVPAVVSKDECIYCFESPYNEPLALNASPKHSLNICLNCFQATCNRHVPLHIRVTEYACDTIHSNYLTIAKVEKPKQENVEENNNNKKIKLQVIETSEDDTHNTIWSLQRFNGENVPRTVLSKSTDSDISSTALEKIEKILKAKSQDFEDKKNSWVLEISTCPHTENFQIPSKPENTVNLNQCSSCDLTQNLWLCLHCGNIGCGREQIGIDGHSHALDHYRSNNNHPLAIKLGSLSSSTYDLYCYACDDETRFPDNVNLGSALQIYGINIQEKIADEKTLVQLQVEQNENWQFRMVDSSGKEFEKLSASKNYGCGLINLGNSCYLNSVIQSLVNGGVPNWSLDFLGSKFPLDVVYPDNNLKCQWIKLLNAMKCEPELYPNGIKPTTFKKCIGQNHQEFSSNRQQDAMEFLTFLLDLLDKKFFSSSSSGIPNPNDLVRFMMEDRLQCNICGKVKYSYEPTEAIQIPLEENDEPQDMLERIKAYFEGQTIEFKCANCKEKVTANKKPGFKSLPQTLILNPIRIRLQNWIPVKTSNELSLPGLIDRDDMLDVSSYLSQGFDPQTENLLPDEDENRSSFTPNQCSISQLIEMGFTQNASVRALFNTGNQDAESAMNWLFQHMDDPDLNDPFVPPPNVPKKDKREVDEVSLTSMLSMGLNPNLCRKALILNNGDVNRSVEWVFNNMDDDGTFPEPEVPNEEQQQKKDLGYSTAKPYALTAVICHKGNSVHSGHYVVFIRKLVADKWKWVLYNDEKLVAADSIEDMKKNGYIYFYTRC 803
2 -165.000[O] KOG0944 Ubiquitin-specific protease UBP14  ali follow..  24  5................TAVRSAVDAGAFIRPTFDQKIFKDQCAYCFKDPHG---------KDGLYISLKNYHAFCREHAEIYGTTS------GNTLFVQFESTKKIIEERTDGEPTSKMTKLTIDSDPKFEFEDKYCVVVHPEYSQQV-------KNVQNLPEIAEAIAQIANTTSAERLSLLSSWDAEIKLITKHQNLEQQDNGKHTGWTCEVEGCGLNDNLWLNLTDGAVRCGRSQFKTNGNGHMQDYFDS-TRFPLVVKLGTISSNLELVYSYDEDDAVIDPN---LEKHLKHFGLDPTKMEKTAKSTMEMELDMNEKWEWSKCTEDGLLLEPI--FGPGYTGLVNTGSSCYMNSVLQALVTVDSFQTRYQGLETLVNCPLDKLHNDFNAQFSKVVRAMLSGDYSSENHIKPLQFKRVAAGNHRDFSTSKQQDVEEYIRFLFEKIAENSRTEVID----PTDSFKFKAINRFEDRGTRRVRYTDQEEMLIRLPIS--------------------GDYISPITGEPKGATNTISMKTFPDYLFFQVSKFAYNDGTQKKLDMELEIEEELDLSGYRGHGKLEHEIALPDEEP--TAPRTTPDIPASVRFVAGELMLMGFCENACYRAA-YYSNGNVEIASNWLMEHMDDSDINDLFVIPSGTPSARG-EVDPNLVASIVEMGFSNHQAKYALKQV-PTVAEAVEWLFANMDSIPVESAAVGPSVTESATQKTFKDGGEKYKLIGMISHMGSRPDSGHYVAHMLK----EGKWVLFNDEKVALSQ--DPPKKLAYVYLYKRI 757
3 -82.100[O] KOG1868 Ubiquitin C-terminal hydrolase  ali follow..  15  4LKVCGFIQIWSQKTGMT----KLKEALIETVQRQKEI---KLVVTFKS---GKFIRIFQLSNNISVVLRHCKK--KNNVFLFIDKLSYRDAKQLNMFLDIIHQNKSQQPMKSDDDWSVFESRNMLKEIDKTSFYSICNKPSYQKMPLFMSKSPTHVKKGILENQGGKGQNTLSSDVQTNEDILKEDNPVPNKKYKTDSLKYIQSNRKNPS------------------------------------SLEDLEKDRDLKLGPSFNTNCNGNPNL--------------------------ETVLATQTLNAKNGLTSPLEPEHSQGDPRCNKAQVPLDSHSQQLQQGFPNLGNTCYMNAVLQSLFAIP--SFADDLLTQGVPWEYI-PFEALIMTLTQLL-ALKDFCSTKIKRELLGNVKKVISAVAEIFSGNMQNDAHEFLGQCLDQLKEDMEKATKVFVCPVVANFEFELQLSLICKACGHAVLKVEPNNYLSINLHQETKPLSIQNSLDLFFKEEELEYNCQMCKQK-SCVARHTFSRLSRVLIIHLKRYSFNNWLLVKNNEQVYIPKSLSLSSYCNESTKPGEKELPVADSLMDQGDISLPVMYEDGGKLISSPDTRLVEVHLQTNTFVEFNFDSVTESTNGFYDCKENRIPEGSQGMEESIIDEFLQQAPPPGVRKLDAQEHTEETLNQSTELRLQKADLNHLGALGSDNPGNKNENTRGEAKELTRNVKMGDPLQAYRLISVVSHIGSSPNSGHYISDVYD--FQKQAWFTYNDLCVSEISETKMQEHSGYIFFYMH. 884
4 -76.900[O] KOG1873 Ubiquitin-specific protease  ali follow..  14  3....................................................................................................KKAKKKARAPTKEIQTMEISKKVSEEPPS---------------------------------------------QAGEIAEGDVKAVKETQACVHFDNLEKVLDKIKSSRQIKCAECN-NKAIWLCLECGCYVCGGVGLPNGPQSHVLRHSRV-TRHRLVIQWENPQL----RWCFPCQLLLPVEKEDNGEKKDVLSEVVKLIKGRSLNNLASSDIEDSGSITSDIKLEGAVTSDIEARDGYVVRGLVNLGNTCFFNSIMQNLLSLDRLRDHF------LKENGSGVGGPLASSLRKLFTETKPEA-GLKSVINPRAFFGSFCSKAPQFRGYDQHDSHELLRCLLDSLSTEESANDEKSTTLIESVFGGETSSIVSCMECGHSSKVYEPFLDLSLPVPFKKKAARIHSADESESKGTQDEEKVITVKRD--ATKKVLINKAPPVLTIHLKRFSQDLGRLSKLNGHVAFKEVIDLRQYMD--------------------------------------------------------------------------------------------------------------------------------------------------------SRCSGEDPPVYRLAGLVEHSG-TMRGGHYVAYVRGGQRVSTAWYNVSDAYVRQVSLEKVLHSEAYILFYER. 956
5 -74.500[O] KOG1867 Ubiquitin-specific protease  ali follow..  16  3............................................................................................................................................................................................AMDTCKHVGQLQLAQDHSSNPQKWHCVDCNTTESIWACLSCSHVACGRY------EEHALKHFQE-SSHPVALEV-----NEMYVFCYLCDDYVLNDNATGDLKLLRRTLSAIKSQNYHCTTRSGRFLRSMGTGDDSYFLHDGAQVTDTVVYQMNECQEKDTGFVCSRQSSLSSGLSGG--ASKGRKMELIQPKEPTSQYISLCHELHTLFQVMWSGKW---ALVSPFAMLHSVWRLIPAFRGYAQQDAQEFLCELLDKIQRELETTIKQVLNVVNNIFHGQLLSQVTCLACDNKSNTIEPFWDLSLEFPERSQPCLVTEMLAKFTETEALEYVCDQCNSKTEAQKQLMICHLPQVLRLHLKRFRWSG-NREKIGVHVGFEEILNMEPYCCRET-----------------------------------------------------------------------------------------------------------------------------------------------------LKSLRPECFIYDLSAVVMHHGKGFGSGHYTAYCYN--SEGGFWVHCNDSKLSMCTMDEVCKAQAYILFYTQ. 677
6 -71.900[Z] KOG2026 Spindle pole body protein - Sad1p  ali follow..  16  6...........................................................................................................................................................................TPANPVEEDETPSVFNPKYRVCPYLDTINRNLLDFDFEK---CSISLTRINVYACLVCGKYFQGR-----GTNTHAYTHSVG-EAHHVFLNLHT-----LRFYCLPDNYEIIDSSLDDI------------------KYVLNPTFTRQEISKLDQLQPKHSRTVDGVLYLPGVVGLNNIKANDYCNVVLHALSHVG--PLRDYFLQKQSYAHVVRPPGDLVQRFGELMRKMWNPRNFKSHVSPHEMLQAVVLWSSKRFQITEQGDPIDFLSWFLNTLHRALKGNKHYTRKMPPVELDDAAKAQLLATEEYKDQVEDKNFIYLTCDLPPPPTDEFRENIIPQVNLYQLLSAEKEYKTYKANFMKRFEITRLPQFIILYIKRFTKNTFFLEKNPTIVNFPIKVDFGDILGMRQ------------------------------------------------------------------------------------------------------------------------------------------------------RDKDVKDTKYNLVANIVHDG-DPKKGTYRAHILH--KANGQWYEMQDLHVTEILPQMITLTESYIQIYER. 478
7 -69.800[O] KOG1864 Ubiquitin-specific protease  ali follow..  17  23....................................................................................................................................................................................................................................................................................................................................................NEHYYGLVNFGNTCYCNSVIQALFFCR--PFREKVLNYKQTLKKSGASKDNLVTCLADLFHSIASQKRRVGTIAPKRFITKLKKENELFDNYMQQDAHEFFNYLINTISETLIQNKSDTTTWIHEIFQGILTNETRCLSCETVSSKDEDFLDLSIDVEQNT---SISHCLRVFSETETLCYFCETCSSKQEAQKRMRIKKPPQLLALHLKRFKFVEPLNRKLSYRVVFPLELRLFNVS----------------------------------------------------------------------------------------------------------------------------------------------------------DDAEYGDRMYDLVATVVHCGATPNRGHYITLVK----SNSFWLVFDDDIVEKLEVSSMMSTDANIQMPPGN 387
8 -69.500[O] COG5533 Ubiquitin C-terminal hydrolase  ali follow..  20  403.............................................................................................................................................................................................................................................................................................................AHAYLPPASNVFSPRIPPLPQQNLSSSRQTILNNSQVLDLDLIVGLENIGNCCYMNCILQCLVGTH--DLVRMFLDNTYLNFINFDSGLLAKNFAILVNNMHRHPNVRTIPVQTIQFKKICGHINPMYSDSMQQDCQEFCQFLLDGLHEDLNQNGSKDFSAIIDLFQGQYASRLQCQVCEHTSTTYQTFSVLSVPVPRVKT-CNILDCFREFTKCERLGWSCPKCLKKQPSTKQLKITRLPKKLIINLKRFDNQM---NKNNVFVQYPYSLDLTPYWARDF-------------------------------------------------------------------------------------------------------------------------------------------NHEAIVNEDIPTRGQVPPFRYRLYGVACHSG-SLYGGHYTSYVYK--GPKKGWYFFDDSLYRPITSTEFITPSAYVLFYERI 804
9 -67.800[O] KOG1872 Ubiquitin-specific protease  ali follow..  18  104........................................................................................................................................................................................................................................................................................................................................................AGLTNLGNTCYMNATVQCLNAVPELRTALSTFSND-GTDTMSTAFSISSAMKSIFAQMEKG-----TTVTPIVLLQALHRASPQFATYRQQDANECWAEILKMLQQKLRPKQKRHSSFIDQFFGGTFEVKMSSEEDPDSTVTSENFLQLSCFI--SMDVKYMQSGLKSKMKEQLV-KKSETLGRDAKYIRTYLVSRLPAYLTVQFVRFQYKEGINAKVLKDIKFPIDFDAFELCTPELQNKLCPMRSKFKDLEDKKMEVDVVKRNEP---------------------------------------------------------------------------------------------------------NEEKKDVKYEQFWFDDDLGSNNSGYYTLQAVLTHKGRSSSSGHYVAWVRS---SGDVWFKFDDDEVSAVATDEILRLCAYVLLYAP. 469
10 -65.800[O] KOG1871 Ubiquitin-specific protease  ali follow..  16  7........................................................................................................................................................................................................................................................................................................................................................RGLTNRSNYCYINSILQALLGCSPFYNLLRSIPKQAAVLSEVKTPSFMTNFSSLPSGLRLRLNQCDMAFEPTEIYKLWNDSREEHVEGRQEDAEEFLGYVLNKLNDEMLEQTDFGRTPVSDIFRGELRSRLQR-EGEHSTDVIQPFFTLQLNIEKAA---SVKEALEILVGRDQLEVTGSKTKQEVVAWQQMTLEKLPVVLILHLKYFDYRSDGCTKILKKVDFPVELKIDAKILGS-------------------------------------------------------------------------------------------------------------------------------------------------------KKTSQKQRAYRLFAVVYHDGKEASKGHYITDVFH--TGYSSWLRYDDSSVKPVSEKHVLQPHPYLLYYRRS 379
11 -56.700[O] KOG1870 Ubiquitin C-terminal hydrolase  ali follow..  15  263.................................................................................................................................................................................................................................................................................................................GDSTSTCGMHSSGVSRGGSGFSASYNCQEPPSSHIQPGLCGLGNLGNTCFMNSALQCLSNTAPLTDYFLKDEYEAEINRDNPKGEIAEAYAELIKQMWSGRD---AHVAPSMFKTQVGRFAPQFSGYQQQDSQELLAFLLDGLHEDLNRVKKKNDSVIVDTFHGLFKSTLVCPECAKVSVTFDPFCYLTLPLPKKKTTVALRDCIELFTTMETLGWYCPNCKKHQQATKKFDLWSLPKILVVHLKRFSYNRYWRDKLDTVVEFPIRLNMSEFV----------------------------------------------------------------------------------------------------------------------------------------------------------CNLSARPYVYDLIAVSNHYG-AMGVGHYTAYAKNK--LNGKWYYFDDSNVSLASEDQIVTKAAYVLFYQR. 922
12 -48.300[O] COG5077 Ubiquitin carboxyl-terminal hydrolase  ali follow..  19  206.................................................................................................................................................................................................................................................................................................................................................SKIATGYVGLKNQGATCYMNSLLQSLYIIHAFRRIVY----QIPTDSPQGKDSIAYALQRCFYNLQFMN----EPVSTTELTKSFG---DSLDSFMQHDVQEFNRVLQDNLERSMRDTKVENA--LTNLFVGKMKSYIACVNVNFESARSEDYWDIQLNVKGMK---NLEDSFRSYIQVETLEYFADTYGFQ-EAKKGVIFESFPPILHLQLKRFEYDRDMMIKINDRYEFPLEFDAKAFLS--------------------------------------------------------------------------------------------------------------------------------------------------------PEADQSQNCEYVLYGVLVHSG-DLHNGHYYALLKT--EKDGPWYKYDDTRVTRATLREVLEESAYMLLYLR. 527
13 -47.600[O] COG5560 Ubiquitin C-terminal hydrolase  ali follow..  14  319...........................................................................................................................................................................................................................................................................................................MFENRLDKITSNPSDLVIEIKPIEGNHHWPSNYFAYNKLEPASGTTGLVNLGNTCYMNSALQCLVHIPQLRDYFLYDGYEDEINEENPHGYVARAFSDLVQKLFQNRMSRNAAFPPSMFKSTIGHFNSMFSGYMQQDSQEFLAFLLDSLHEDLNRHLKRNCSVITDLFVGMYKSTLYCPECQNVSITFDPYNDVTLPLPVDTRTITLDDCLQLFSKPEILGWYCPTCKEHRQATKQIQLWNTPDILLIHLKRFESQRSFSDKIDATVNFPITLDLSRYV---------------------------------------------------------------------------------------------------------------------------------------------------------VYKDDPRGLIYDLYAVDNHYG-GLGGGHYTAYVKNF--ADNKWYYFDDSRVTETAPENSIAGSAYLLFYIR. 1109
14 -47.500[O] KOG1865 Ubiquitin carboxyl-terminal hydrolase  ali follow..  22  80........................................................................................................................................................................................................................................................................................................................................................AGLQNMGNTCYVNASQQCLTYIPP--------------------------------------------------------------------------------------------------LANYMLSREHSQTCHRHKCCMLCTMEAHITWPLHIP--GHVIQPSQALAAGFHEAALEFLMFTVDAMKKACLPGHKQILILVWKRFS--DVTGNKIAKNVQYPECLDMQPYM----------------------------------------------------------------------------------------------------------------------------------------------------------SQQNTGPLVYVLYAVLVHAGWSCHNGHYFSYVK---VQEGQWYKMDDAEVTASGITSVLSQQAYVLFYIQ. 282
15 -26.500[R] KOG0804 Cytoplasmic Zn-finger protein BRAP2 (BRCA1 associated protein)  ali follow..  11  142....................................FYKYNDEKLTKVAQCRMLCM--AVPAQVEV-IISFMCISLPMIV------------------SIKVVR-------DPAPNQYMLIIKFKEHNDAVTFYEEFNNCPFNDLESYCCTLFRIECTTSNDLFSSDDTSLTELPTCAVCLERMDDSVLAILCNHSFHARCLEQSPEVVAEQRCNDCGMSNDLWICLICGNIGCGRYA-----EQHAQRHWEL-TSHTYSLKVGGER-----VWDYAGDNYVENGADGKLVEYQRESNASFDDKNQKGGDKLEGIKLEYTLLLTSQLEDQRK----------------------YFEGLRHDMEQTMSKMEKTAYAQVENLEHQLTERSTELKSLKGDLDDTVTARKVAEKRAT--QTNEKVNKLANELK--DEREINQMLRKDQQVWKGQVEKLIESQKTARTEY--------------KKIEDLQSQVNDLLMHFETQNKLKEQLDA-QEEITESQVELDSSSSSSRKLNRKKKK.......................................................................................................................................................................................................................................................................... 590
16 -13.300[OT] KOG2561 Adaptor protein NUB1, contains UBA domain  ali follow..  11  1...................................................................................................................................................................MSQINNIFIKLRARLRERDIKLWEEPYYFEEEMDRLARDISGELGISVSDC--RIALGEL--------------------QDGALRKLAARREFN--------DTGLATFNVRCVDSKGGTVQMLEIKCSLGGLGSDLQAEVAKKLDIVDSS----------KCISGGRIINGQKTLAS--QGLKT-------QHLMVVVGGTNEGQELHERIQRIRADLELVADADRFMEMEDQDGRPIFLPREENRSLLMAMSMYEVAR-----VAMHKENFDEALLILLEADEL-------------------------QCDS--KLLEGVDNYALINLDIDAQRRLDICERGFVKSYGEQFIRLFSIKGPSSPERALIMRLHLLQGVLLFHQNR-------------------------------------RDEAYEKLEVATKDLYEVKMNDTELSTLVEMGYEESDARLALRSCAG-QVDRAIQYIQERSERISEERKNSAAERQVNQEMIFVNPRSIIRLMEMGYERRLVVEALKRTKNNLDRSLDLLQRHSDELRANLPPIPPVDE---------------SLLTTLQHLG------------------------FSEISARDATGNSFHKSLKFLL..... 512
17 -11.100[S] COG4855 Uncharacterized protein conserved in archaea  ali follow..  14  16.................................................................................................................................................................................................................DCMKCYVCAEQGKVAICIVCGMGLC---------TEHAIREETEIWSGGYPFPAEKVKGTLPRILCPYCYNVMKED...................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... 86
18 -10.500[DR] KOG1101 Apoptosis inhibitor IAP1 and related BIR domain proteins  ali follow..  8  1.............................MHKTASQRLFPGPSYTYSTPAGVPVSERSLARAGFYYCFCCGLML-DNWKLGDSPIQKHKQLYPSCSFIQNLVSASLGSTSKNTSPMRNSFAHSLSPTLEHSSLFSGS----------YSSLSPNPLNSRAVEDISSSRTNPYSYAMSTEEARFLTYHMWPLTFLSPSELARAG----PGDRVACFACGGKLSNW----------------EPKDDAMSEHRRHFPNCPFLENSLEYVGRNDDVKCFCCDGGLRESGDDPWVEHAKWFQEFVDEIQGRYPHLLEQLLSTSDTTGEENADPPIIHVKQTVQSKILTTGENYKTVSALLKQAEEMASDDLSLIRKNRMALFQQLTCVLPILDNLLKANVINKQEHDIIKQKTQIPLQARELIDTILVKGNAFKNCLKEIDSTLYKNLFVDKNMKYIPTEDVSGLSLEEQLR-RLQEERTCKVCMD-----KEVSVVFIP----GHLVVCQECAPSLRK-------CPICRGIIKGTVRTFLS........................................................................................................................................................................................................................................................................ 618
19 -9.740[S] KOG4367 Predicted Zn-finger protein  ali follow..  11  2..................................EEMEEEKCPVCYREP----------------IILPCSHNLCQACARNILVQTPESESPQSH-------RAAGSGVSDYDYLDLDKMSLYSEADSGYGSYGGFASAPTTPCQKSPNGVRVFPPAMPPPATHLSPANSCITCPQCHRSLILDDRGLRGFPKNRVLEGVIDRYQQSKAAALKCQLCEKAPKTVMCEQCDVFYCDP----------LRCHRGPLAKHRLVSTCTDHELENHSMYCVQCKMPV-------------------------------LEEGKHSSHEVKALGAMWKLHKSQ---------LSQA-----LNGLSDRAKEAKEFLVQLRNMVQQIQENSVEFEACLVAQCDALIDALNRRKAQLLARVNKEH-LKVVRDQISHCTVKLRQ-----TTGLMEYCLEVIKENDPSGFLQISDALIRRVHLTEDQWGKGTLTPRMTTDFDLSLDNSPLLQSIHQLDFVQV................................................................................................................................................................................................................................................................................................... 434
20 -9.540[PT] KOG4294 Non voltage-gated ion channels (DEG/ENaC family)  ali follow..  13  282........................................NC-YTFNNRENETSTSMGGSEYGLQVILY---------INEEEYNPFLVSSTGAKVIIHRQDEYPSVEDVGTEIETTMVTSIGMHLT-------------------------------------------ESFKLSEPSSQCTEGGSDVPIRNIYNAAYSLQI----------CHSCFQTKMVEKC------GCAQYSQPLPPAANYCNYQQHPNWMYCYYQLRAFVQEELGCQS-ACRFKEWTLTTSLLLPVLTWDQGRQVNKKLNKTDLAKLLIFYKDLNQRSIMESPANSIEMLLSNFGGQLGL--MSCS--VVCVIEII........................................................................................................................................................................................................................................................................................................................................................................................................................................................ 550
21 -9.360[IG] KOG1340 Prosaposin  ali follow..  10  292QLVKHLRDVLVANTTETEFKQVMEGFCKQSKG-----FKDECLSIVDQYYHVIYETLVSKLDANGAC--CMIGICQKNSASSMKDVPIMPLLPVIEPAQVKITIEKLEKHEQQEILDMQLPIDHLMGAANPGALVEGGELCTLCEYMLHFIQETLATPSTDDEIKHTVENICAKLPSGVAGQCRNFVEMYDVCPLMQMCPKNLPKKEEQDPPTCPLCKSKDNIKKVLNCSHL-C----------VDFVNTYSNE-----LIDMLITDFKPQEI-CVQCPKTTYALWDLRIKSSSEEISFNDIESLEELPPQLAFDPGFTAAPNCLICEELVKTLEKRMGKHPTRDSIKHLEESCYGDKIADLLLKEMDPKLICTELGRQDNKLSSSIKEPPTCVLCEFI--MTKLDADLKNKTEQDDIKRAIEAVCNRLPATVRKQCDTFVDGYASAVLKLLSDVPPKQVCQKLQLCF-EVLECGVCHGVTQALLPFLRE------KKDNVSEVTALQMTSVGCENLPAKYY-KICSEMISIYGSSIKNLAQSHICAEIG............................................................................................................................................................................................................................................................. 936
22 -9.080[O] COG1180 Pyruvate-formate lyase-activating enzyme  ali follow..  13  9.............................................................................................................................................................................................................KKEDGRIRCLACARK-----CIGEGQVGCGVRS-VRNGKLYLDVYGKIAAAHIDPIEVFSFSTYGCNWMCMYCQNYDISQRRKAEGVELSPEEIVELAMGYDVDGMTYTYNEPAIFSEFAHDVGIVAKRY----------GLFNTMVSNYWTNLVDYVKDLDAVTIDFKGNGEQKFLRRYTGATSAEPIIETASELSKKGIHVEITDLIIPQI------------GDDLQAAKQLLTKLYDQLGAKLNYIPWTPVETLERHYKLAKELGFKCPNCGNLVIRRYSFDILEWHLTEDM--------------------RCKFCGYKLPIR.............................................................................................................................................................................................................................................................................. 334
FFAS is supported by the NIH grant R01-GM087218-01
1 4 8 1 0 5   jobs submitted since Jan 1, 2011
Comments and questions to: webmaster
Selected papers from Godzik Lab
Ying Zhang, Ines Thiele, Dana Weekes, Zhanwen Li, Lukasz Jaroszewski, Krzysztof Ginalski, Ashley Deacon, John Wooley, Scott Lesley, Ian Wilson, Bernhard Palsson, Andrei Osterman, Adam Godzik. Three-Dimensional Structural View of the Central Metabolic Network of Thermotoga maritima. Science. 2009 Sep 18;325(5947):1544-9.

Mayya Sedova, Mallika Iyer, Zhanwen Li, Lukasz Jaroszewski, Kai W Post, Thomas Hrabe, Eduard Porta-Pardo, Adam Godzik Cancer3D 2.0:: interactive analysis of 3D patterns of cancer mutations in cancer subsets. Nucleic Acids Research, gky1098 2018; Published on November 8 2018.

Li W, Godzik A. cd-hit: a fast program for clustering and comparing large sets of protein or nucleotide sequences. Bioinformatics. 2006 May 26;